SEC Tracker
Get the app
QIPT · As filed with the SEC

Quipt Home Medical cash flow statement, by fiscal year

The statement as Quipt Home Medical presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONSOLIDATED STATEMENTS OF CASH FLOWS · USD

USDFY2025
Year ended Sep 30, 2025		FY2024
Year ended Sep 30, 2024		FY2023
Year ended Sep 30, 2023		FY2022
Year ended Sep 30, 2022
Operating activities
Net loss—(6,763,000)——
Net loss(10,701,000)———
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization45,482,00044,581,000——
Stock-based compensation4,035,0002,484,000——
Gain on disposals of property and equipment(1,225,000)(107,000)——
Amortization of financing costs and accretion of purchase price payable563,000551,000——
Gain on foreign currency transactions—(43,000)——
Loss (gain) on foreign currency transactions367,000———
Share of loss in equity method investment324,000309,000——
Change in fair value of derivative liability - interest rate swap(452,000)1,122,000——
Deferred income taxes85,000342,000——
Right-of-use operating lease amortization and interest6,434,0005,974,000——
Payments of operating leases, including interest(6,138,000)(5,386,000)——
Adjustments to purchase price payable—(29,000)——
Change in working capital, net of acquisitions:
Net decrease (increase) in accounts receivable2,575,000(3,294,000)——
Net increase in inventory(2,417,000)(3,420,000)——
Net decrease (increase) in prepaid and other current assets2,193,000(3,124,000)——
Net decrease in deferred revenue(21,000)(943,000)——
Net increase (decrease) in accounts payables and accrued liabilities(3,412,000)3,127,000——
Net cash flow provided by operating activities37,692,00035,381,000——
Investing activities
Purchase of property and equipment(12,354,000)(10,313,000)——
Cash proceeds from sale of property and equipment1,233,000210,000——
Cash paid for acquisitions, net of cash acquired(21,824,000)(210,000)——
Net cash flow used in investing activities(32,945,000)(10,313,000)——
Financing activities
Repayments of equipment loans and SBA loan—(26,792,000)——
Repayments of equipment loans(24,472,000)———
Repayments of finance leases(1,436,000)(1,579,000)——
Borrowings on delayed-draw term loan17,400,000———
Repayments of delayed-draw term loan and term loan(3,668,000)(3,450,000)——
Gross borrowings on the revolving credit facility18,250,00017,100,000——
Gross repayments on the revolving credit facility(13,623,000)(10,777,000)——
Issuance costs relating to credit facility—(60,000)——
Other, net(79,000)———
Repurchase of shares, net of issuance costs(130,000)———
Settlement of restricted stock units—(213,000)——
Proceeds from exercise of stock options—568,000——
Payments of purchase price payable—(944,000)——
Net cash flow (used in) provided by financing activities(7,758,000)(26,147,000)——
Net increase (decrease) in cash(3,011,000)(1,079,000)——
Effect of exchange rate changes on cash held in foreign currencies(247,000)44,000——
Cash, beginning of year16,174,00017,209,000——
Cash, end of year12,916,00016,174,000——
Supplemental cash flow information
Cash paid for interest(5,914,000)(6,826,000)——
Cash paid (refunded) for income taxes425,000(1,249,000)——
Operating lease additions2,074,0004,229,000——
Equipment loan additions23,828,00025,304,000——
Finance lease additions842,0001,975,000——
Purchases of property and equipment in ending accounts payable2,161,000214,000——
Net income (loss)——(2,784,000)4,839,000
Depreciation and amortization——40,163,00023,040,000
Stock-based compensation——5,280,0005,493,000
Loss (gain) on disposal of property and equipment——(75,000)45,000
Other income from government grant———(4,885,000)
Loss on extinguishment of debt——30,000281,000
Amortization of financing costs and accretion of purchase price payable——591,000251,000
Interest expense, net of amortization and accretion——6,016,0001,828,000
Cash paid for interest——(6,026,000)(2,007,000)
Loss (gain) on foreign currency transactions——(108,000)144,000
Share of loss in equity method investment——89,000—
Loss (gain) loss on fair value of convertible debentures———(1,150,000)
Loss on settlement of shares to be issued———442,000
Provision (benefit) for income taxes——85,000(1,904,000)
Cash paid for income taxes——(680,000)(653,000)
Adjustments to purchase price payable——(96,000)(178,000)
Net increase in accounts receivable——(3,063,000)(201,000)
Net increase in inventory——(60,000)(2,419,000)
Net (increase) decrease in prepaid and other current assets——(2,239,000)450,000
Net increase in deferred revenue——240,00031,000
Net increase in accounts payables and accrued liabilities——3,173,0002,897,000
Net cash flow provided by operating activities——40,536,00026,344,000
Purchase of property and equipment——(6,852,000)(9,161,000)
Cash proceeds from sale of property and equipment——65,000193,000
Cash paid for acquisitions, net of cash acquired——(76,038,000)(33,525,000)
Net cash flow used in investing activities——(82,825,000)(42,493,000)
Repayments of loans——(20,447,000)(11,900,000)
Repayments of leases——(4,377,000)(3,822,000)
Proceeds from credit facility———12,000,000
Issuance of debt under senior credit facility——64,000,000—
Repayments of senior credit facility——(2,650,000)—
Net (payments) borrowings on the revolving credit facility——(7,000,000)—
Issuance costs relating to credit facility——(581,000)(1,779,000)
Issuance of shares, net of issuance costs——27,866,000—
Settlement of restricted stock units——(1,338,000)—
Proceeds from exercise of stock options——484,000567,000
Cash in lieu of shares to be issued———(1,100,000)
Payments of purchase price payable——(5,083,000)(3,817,000)
Net cash flow (used in) provided by financing activities——50,874,000(9,851,000)
Net increase (decrease) in cash——8,585,000(26,000,000)
Effect of exchange rate changes on cash held in foreign currencies——108,000(96,000)
Cash, beginning of year—17,209,0008,516,00034,612,000
Cash, end of year——17,209,0008,516,000

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.